IK-264

Chemical Name: (8aS,12aR)-2-(2,4-Dichlorophenyl)-6,7,8a,9,10,11,12,12a-octahydro-5H-pyrido[3',4':4,5]pyrrolo[1,2,3-ef][1,5]benzothiazepine
项目整合开发状态: Preclinical
项目研究机构: Bristol-Myers Squibb (Originator)
合成路线:Condensation of substituted aniline (I) with acrylic acid (II) in toluene affords bicyclic derivative (III),whose carbonyl is reduced by means of Red-Al in toluene to yield compound (IV).Conversion of (IV) into bicyclic hydrazine (V) is then performed by treatment with NaNO2 and HOAc followed by reduction of the resulting diazo derivative with LiAlH4 in THF.Derivative (V) is then subjected to a Fisher indole cyclization process by reaction with ketone (VI) and HCl in iPrOH to provide compound (VII),which is then regioselectively reduced with NaCNBH3 in TFA to give tetracyclic indoline (VIII).N-Protection of (VIII) with Boc2O and NaOH affords Boc protected derivative (IX),which is then selectively brominated by means of NBS in DMF to yield bromo derivative (X).Finally,the desired compound is obtained by a Suzuki cross-coupling reaction between (X) and boronic acid (XI) catalyzed by Pd(PPh3)4,followed by Boc removal with TFA in CH2Cl2.